L. Saunders - Nov 8, 2022 Form 3 Insider Report for ARS Pharmaceuticals, Inc. (SPRY)

Role
Director
Signature
/s/ Kathleen Scott, Attorney-in-Fact
Stock symbol
SPRY
Transactions as of
Nov 8, 2022
Transactions value $
$0
Form type
3
Date filed
11/10/2022, 04:00 PM
Previous filing
Jun 24, 2022
Next filing
Dec 12, 2022

No securities are beneficially owned.